Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1997 Publications

  1. Chan, K.K., R. Bakhitar and C. Jiang, 1997. Depsipeptide (FR901228, NSC-630176) Pharmacokinetics in the Rat by LC/MS/MS. Invest. New Drugs, 15, 195-206.
  2. Egorin, M.J., Rosen, D.M., Benjamin, S.E., Callery, P.S., Sentz, D.L., Eiseman, J.L., 1997. In Vitro Metabolism by Mouse and Human Liver Preparations of Halomon, an Antitumor Halogenated Monoterpene, Cancer Chemother. Pharmacol., 41(1), 9-14.
  3. Erickson-Miller, C.L., R.D. May, J. Tomaszewski, B. Osborn, M.J. Murphy, J.G. Page and R.E. Parchment, 1997. Differential Toxicity of Camptothecin, Topotecan, and 9-Aminocamptothecin to Human, Canine and Murine Myeloid Progenitors (CFU-GM) In Vitro. Cancer Chemother. Pharmacol., 39, 467-472.
  4. Fuse, E., Nishiie, H., Kobayashi, H., Ikeda, S., Saito, H., Covey, J., and Kobayashi, S, 1997. Disposition of DX-52-1, a Novel Anticancer Agent, after Intravenous Administration to Mice and Dogs. Eur. J. Drug Metab. Pharmacokinet., 22, 53-63.
  5. Newman, R.A., Chen, W., Madden, T., 1997. HPLC Measurement of the Novel Nonnucleoside Anti-HIV Agent (+)-Dihydrocalanolide A, J. Liquid Chromatogr. & Related Technologies, 20(4), 651-659.
  6. Rodman, L.E., D.R. Farnell, J.M. Coyne, P.W. Allan, D.L. Hill, K.L.K. Duncan, J.E. Tomaszewski, A.C. Smith and J.G. Page, 1997. Toxicity of Cordycepin with the Adenosine Deaminase Inhibitor, 2'-Deoxycoformycin, in Beagle Dogs. Toxicol. Appl. Pharmacol., 147, 39-45.
  7. 47. Tomaszewski, J.E. and A.C. Smith, 1997. Chapter 23. Safety Testing of Antitumor Agents. In Comprehensive Toxicology, Toxicity Testing and Evaluation. Eds., P.D. Williams and G.H. Hottendorf, Elsevier Science Ltd, Oxford, England, Vol. 2, pp. 209-399.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director,